Mezzasalma Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,362
Closed -$348K 102
2023
Q4
$348K Sell
4,362
-15
-0.3% -$1.13K 0.19% 61
2023
Q3
$311K Sell
4,377
-90
-2% -$6.73K 0.19% 62
2023
Q2
$344K Hold
4,467
0.21% 59
2023
Q1
$336K Hold
4,467
0.24% 59
2022
Q4
$352K Sell
4,467
-475
-10% -$35.6K 0.31% 52
2022
Q3
$347K Hold
4,942
0.28% 50
2022
Q2
$396K Hold
4,942
0.33% 47
2022
Q1
$375K Sell
4,942
-100
-2% -$7.92K 0.23% 58
2021
Q4
$430K Buy
5,042
+85
+2% +$6.64K 0.23% 56
2021
Q3
$375K Hold
4,957
0.21% 57
2021
Q2
$403K Hold
4,957
0.22% 55
2021
Q1
$391K Sell
4,957
-45
-0.9% -$3.53K 0.25% 53
2020
Q4
$428K Buy
+5,002
New +$414K 0.27% 51

Other funds holding CL

Mezzasalma Advisors's CL Position: Q1 2024 in Review

Mezzasalma Advisors sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 4,362 shares — an estimated $348K sold.

Mezzasalma Advisors first reported a position in CL in Q4 2020 and held it in 13 quarters. The position peaked at $430K in Q4 2021. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Mezzasalma Advisors reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
  • Mezzasalma Advisors sold 4,362 Colgate-Palmolive shares in Q1 2024, an estimated $348K.
  • Mezzasalma Advisors first reported a position in Colgate-Palmolive in Q4 2020 and held it in 13 quarters.
  • Mezzasalma Advisors's Colgate-Palmolive position peaked at $430K in Q4 2021.
  • 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Mezzasalma Advisors's 13F filing for Q1 2024, filed 19 Apr 2024.